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Abstract 
Human aquaporin 4 (AQP4) is the primary water channel protein in brain astrocytes. 
Hypothermia is known to cause astrocyte swelling in culture, but the precise role of AQP4 in 
this process is unknown. Primary human cortical astrocytes were cultured under 
hypothermic (32oC) or normothermic (37oC) conditions. AQP4 transcript, total protein and 
surface localized protein were quantified using RT-qPCR, sandwich ELISA with whole cell 
lysates, or cell-surface biotinylation followed by ELISA analysis of the surface-localized 
protein, respectively. Four-hour mild hypothermic treatment increased the surface 
localization of AQP4 in human astrocytes to 155 ± 4% of normothermic controls, despite no 
change in total protein expression levels. The hypothermia-mediated increase in AQP4 
surface abundance on human astrocytes was blocked using either calmodulin antagonist 
(trifluoperazine; TFP); TRPV4 antagonist, HC-067047 or calcium chelation using EGTA-AM. 
The TRPV4 agonist (GSK1016790A) mimicked the effect of hypothermia compared with 
untreated normothermic astrocytes. Hypothermia led to an increase in surface localization of 
AQP4 in human astrocytes through a mechanism likely dependent on the TRPV4 calcium 
channel and calmodulin activation. Understanding the effects of hypothermia on astrocytic 
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AQP4 cell-surface expression may help develop new treatments for brain swelling based on 
an in-depth mechanistic understanding of AQP4 translocation. 
 
Introduction 
Hypothermia is known to have specific effects on the blood brain barrier (BBB), including 
changes in blood flow, metabolism, water homeostasis and excitoxicity, as well as signaling 
profiles leading to changes in apoptosis and cell survival (Yenari & Han, 2012). Hypothermia 
was reported to be neuroprotective in stroke patients (Yenari & Hemmen, 2010) but in 
traumatic brain injury (TBI), a therapeutic role for hypothermia is controversial; different 
clinical trials have reported both positive and negative outcomes on patient recovery 
(Andrews et al., 2015; Lazaridis & Robertson, 2016). Cytotoxic oedema, which is a feature of 
stroke and TBI, occurs when water enters the CNS via astrocytes at the BBB, predominantly 
through the aquaporin 4 (AQP4) channel and knockout of AQP4 is protective against 
cytotoxic oedema development in various animal models (Verkman et al., 2006). The 
specific effects of hypothermia on AQP4 expression in human astrocytes are not known. 
AQP4 expression in rat astrocytes has been reported to increase after 2h in response to 
transarterial (cold saline) hypothermia infusion in a middle cerebral artery occlusion (MCAO) 
model (Kurisu et al., 2016). In a rat model of thrombin-induced vasogenic oedema, AQP4 
protein levels increased after 24h, peaking at 48h (Gao et al., 2015). Conversely, 
hypothermia-induced reduction in cytotoxic cerebral oedema, in a porcine model of cardiac 
arrest/resuscitation, was concomitant with a reduction in AQP4 protein levels after 24 h 
(Zhao et al., 2012). Additionally, mild hypothermia was reported to cause a significant 
astrocyte volume increase to 107.3 ± 0.4% (mean ± SEM) of control, after 30 min at 32oC 
(Plesnila et al., 2000). 
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Many factors have been reported to alter AQP4 abundance and subcellular localization, 
including vasopressin, histamine and astrocytic glutamate (Conner et al., 2013). We recently 
described a mechanism of short-term AQP4 relocalization during tonicity-driven cell swelling 
in rat astrocytes (Kitchen et al., 2015). To our knowledge, hypothermia has not been 
previously investigated as a trigger of AQP4 relocalization.  
In addition to AQP4, the stretch-activated transient receptor potential vanilloid 4 calcium 
channel (TRPV4) is known to be essential in cell volume regulation: a TRPV4-mediated 
increase in Ca2+ influx has been suggested to have an effect on the AQP-mediated cell 
volume regulation following osmotic stress and the activity and localization of TRPV4 was 
often dependent on aquaporin expression (Benfenati et al., 2011). They proposed a 
TRPV4/AQP4 complex at the astrocyte membrane was an essential component of an 
osmosensory system that couples osmotic stress to downstream signaling pathways 
(Benfenati et al., 2011). 
This study demonstrates that mild hypothermia, as used therapeutically (32oC), can increase 
the localization of endogenous AQP4 to the plasma membrane of human primary cortical 
astrocytes and that this process can be disrupted by inhibition of TRPV4 or calmodulin and 
by chelation of intracellular calcium. Given the well-established permissive role of AQP4 in 
cytotoxic oedema development, our data may help to explain why hypothermic intervention 
in conditions involving cytotoxic oedema is sometimes deleterious and suggest novel 
hypothermic/pharmacological combination therapies for cytotoxic oedema. 
 
Materials and methods: 
Cell culture: Primary human cortical astrocytes (Sciencell) were used following the 
manufacturer’s protocol. All cells were used at passage 4 or below. The cells were incubated 
in humidified 5% (v/v) CO2 in air at 37°C or 32°C.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
RT-qPCR: Total RNA was isolated using a Qiagen RNeasy plus mini kit (Qiagen), according 
to the manufacturer’s instructions and multi-target RT-qPCR was performed using a 
StepOnePlusTM Real-Time PCR System (Applied Biosystems) with purified cDNA samples 
generated using SuperScript™ III Reverse Transcriptase (ThermoFisher Scientific) and 
QIAquick PCR Purification Kit (Qiagen) to investigate gene expression levels of AQP4 
mRNA using Taqman primers (Thermofisher; ID: Hs00242342_m1). PPIA (assay ID: 
Hs99999904_m1) and CDKN1B (assay ID: Hs00153277_m1) (Applied Biosystems) were 
used as control housekeeping genes. Results were analyzed using the 2–ΔΔCt method and 
presented as relative gene expression normalized to the average cycle threshold for the two 
housekeeping genes.  
 
ELISA: AQP4 and calmodulin protein levels were measured by sandwich ELISA following 
the manufacturer’s instructions (Abcam) and as described by (Salman et al., 2017), using 
rabbit polyclonal anti-AQP4 antibody (Abcam, ab46182) and mouse monoclonal anti-AQP4 
antibody (Abcam, ab9512) or rabbit polyclonal anti-calmodulin antibody (Abcam, ab38590) 
with mouse monoclonal anti- calmodulin antibody (Abcam, ab2860). The secondary antibody 
used in both assays was chicken anti-mouse IgG-HRP antibody (Santa Cruz, sc-2954).  
 
Cell surface biotinylation (CSB):  This was performed as described by (Kitchen et al., 2015). 
Briefly, cell surface proteins were biotinylated using a cell-impermeable amine-reactive 
biotinylation reagent (EZ-Link Sulfo-NHS-SS-Biotin; Thermo Cat. No. 21331). 96-well 
Pierce™ NeutrAvidin™ coated plates, (Thermo Scientific; Cat. No. 15129) were used to pull 
down the biotinylated proteins within the total cell lysate. After washing off unbound proteins, 
the plate was then incubated with anti-AQP4 antibody (Abcam, ab128906) diluted 1:500 in 
0.05% PBS-tween (PBS-T), which bound to the cell-surface biotinylated AQP4 proteins 
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attached to the avidin coated plate. Anti-AQP4 antibody validation data is provided in 
supplementary data Figure 1. 
 
Cell Treatments: Hypotonic challenges were achieved by dilution of media with dH2O to 85 
mOsm/kg H2O; Osmolality was measured using an Osmomat 3000 freezing point 
depression osmometer (Gonotec). Inhibitors were used at 100x published IC50 values were 
added 30 minutes prior to initiation and maintained for the duration of each experimental 
setting. TRPV4 inhibitor (HC-067047) was used at a concentration of 4.8µM; while 
calmodulin antagonist (trifluoperazine; TFP) was used at a concentration of 127µM. The 
potent TRPV4 channel agonist GSK1016790A (Sigma) was used at a concentration of 2.1 
µM; it was either added 30 minutes before the intervention or at the same time as the 
intervention. Intracellular calcium chelation was performed using EGTA AM (Invitrogen; 
E1219) at a concentration of 5 µM following the manufacturer’s recommendation. In all 
cases, cells were at least 92% viable, assessed using CellTiter-Glo® Luminescent Cell 
Viability Assay. 
 
Statistical analysis   
All data are presented as a fold-change normalized to the experimental control.  
RT-qPCR expression, ELISA and cell surface biotinylation data were found to be 
nonparametric in distribution using the Shapiro-Wilk test. A Kruskal–Wallis analysis with a 
Conover– Inman post hoc test was therefore used to identify significant differences (p ≤ 
0.05) using StatsDirect 3 software. Additionally, data have been reproduced as box-and-
whisker plots and are provided collectively in supplementary Figure 2. 
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Results 
RT-qPCR and ELISA of AQP4 following hypothermia in primary human astrocytes 
There was a modest increase in AQP4 mRNA levels in cultured human primary astrocytes 
(measured using RT-qPCR) following 4h mild hypothermia (32oC) compared with control 
cells grown at 37oC (Figure 1A): the increase was 156% ± 16%; p = 0.035 (n=4). However, 
Figure 1B shows that this small increase in transcript abundance was not translated into a 
change in protein levels (measured by ELISA), which were not significantly different (p > 
0.05). 
 
AQP4 plasma membrane abundance using cell surface biotinylation following 
hypothermia in primary human astrocytes 
Cell-surface AQP4 expression after 4h mild hypothermia (32oC) was compared to cells at  
37oC  using an AQP4 biotinylation assay (as described in our previous study  (Kitchen et al., 
2015)). The results show that despite there being no change in total AQP4 protein levels 
(Figure 1B), AQP4 levels at the cell surface increased to 155  4% (p<0.0001), of control 
values following hypothermia (Figure 2); the modest decrease in surface localization of the 
control membrane protein, amino acid transporter EAAT1, indicates that the hypothermia-
induced increase in AQP4 plasma membrane localization is not a global response to 
hypothermia associated with all membrane proteins. 
 
Hypotonicity is known to cause cellular swelling and increase in AQP4 surface localization 
and was used a positive control. Figure 2 shows that hypotonicity significantly increases the 
AQP4 levels at the cell surface to 192  11% (p<0.0001) of control values with no significant 
difference in EAAT1 levels (p=0.579). 
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Validation of calmodulin- and TRPV4- dependent mechanism in AQP4 translocation 
following hypothermia in primary human astrocytes 
We previously identified a regulatory mechanism for AQP4 surface localization in an in vitro 
model using rat astrocyte cell swelling in response to reduced extracellular osmolality 
(Kitchen et al., 2015). Calmodulin was a key regulator of this process and extracellular Ca2+ 
was essential to mediate the translocation. We therefore measured the localization of AQP4 
following inhibition of either calmodulin (using TFP); TRPV4 (using HC-067047) or calcium 
(using EGTA-AM); Figure 3 shows that all the investigated inhibitors blocked relocalization of 
AQP4 in human primary astrocytes following 32oC hypothermia. We have previously shown 
no effect of either TFP or removal of extracellular calcium on the initial (i.e. pre- swelling-
induced relocalization) distribution of AQP4 in rat astrocytes  (Kitchen et al., 2015) 
suggesting TRPV4 and calmodulin inhibition are disrupting this hypothermic relocalization 
phenomenon. 
 
The data in Figure 3 indicated that calmodulin activation is required for AQP4 relocalization. 
Therefore, we assessed calmodulin protein levels under the same hypothermic conditions. 
Our data showed that 4h mild hypothermia (32oC) significantly increased calmodulin 
expression to 158 ± 5% (p<0.0001) compared with cells grown at 37oC (n=4). 
 
The involvement of TRPV4 was investigated further using the TRPV4 agonist, 
GSK1016790A. Figure 4 shows that treating astrocytes with GSK1016790A causes a 
significant increase in AQP4 surface expression, 145 ± 10% (p=0.0042) compared to control 
levels, similar to what was observed after hypothermia. Interestingly, there was no additive 
effect of TRPV4 agonist and hypothermia. Agonist was added 30 minutes before 
hypothermia in order to follow the same experimental protocol used for the antagonists. We 
speculated that this ‘pre-treatment’ may have caused internalization of TRPV4 (which has 
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been reported for GSK1016790A) (Shibasaki et al., 2015), leading to absence of TRPV4 at 
the surface for activation by hypothermia. To test this, we repeated the experiment applying 
the TRPV4 agonist and hypothermia simultaneously. In this case, an additive effect of 
TRPV4 agonism and hypothermia was seen, with AQP4 surface expression increasing to 
183 ± 4% (p=0.0003) of control, significantly higher than either TRPV4 agonist alone 
(p=0.0039) or hypothermia alone (p=0.025). The same additive effect was observed 
following hypotonic intervention: AQP4 surface expression was increased to 189 ± 10% 
(p=0.045) with TRPV4 agonist pre-treatment, and 223± 5% (p=0.0253) with simultaneous 
treatment.  
 
There were no significant changes in EAAT1 surface expression levels following the 
agonist/inhibitors in figures 3 and 4 (data not shown). 
 
Discussion 
Hypothermia affects many physiological mechanisms of the brain and has a widely-
recognised therapeutic potential in the reduction of early stage (cytotoxic) oedema (Previch 
et al., 2016). This oedema can form when astrocytes have reduced ion homeostasis and 
increased intracellular tonicity, which is followed by water influx via osmosis. This in turn is 
thought to activate the mechanosensitive calcium channels (mainly TRPV4) leading to an 
increase in calcium influx (Benfenati et al., 2011) enhancing calmodulin activity, including 
calmodulin-mediated AQP4 surface relocalization (Verkman et al., 2014; Vella et al., 2015). 
The proposal that hypothermia influences important cellular signalling mechanisms is 
supported by recent work showing that hypothermia/TRPV4 mediated effects on intracellular 
signaling (Zou et al., 2015). 
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To our knowledge this is the first demonstration of changes to AQP4 surface localization 
levels in response to hypothermic treatment of human primary cortical astrocytes. We have 
also demonstrated that inhibiting calmodulin (using either the antagonist, TFP or the TRPV4 
inhibitor, HC-067047) or intracellular calcium (using EGTA-AM), blocks the hypothermia-
mediated increase in AQP4 surface expression in human astrocytes. Interestingly, it has 
been shown that TRPV4 activity is inhibited by cold (temperature < 34 oC) in mouse neurons 
(Shibasaki et al., 2015). It is also well-established that TRPV4 opens in response to cell 
swelling, but the calcium signalling responses are different in neurons (fast, inactivating 
currents) and glia (slow currents, with sustained [Ca]2+i elevation) (Ryskamp et al., 2014). In 
astrocytes, where hypothermia induces cell swelling, it is not obvious whether TRPV4 would 
be activated by mechanical swelling, inactivated by cold, or at intermediate activity, 
depending on the exact temperature and cell volume. Our data suggest that TRPV4 retains 
at least some activity in astrocytes at 32 oC, as the AQP4 relocalization observed in 
response to hypothermia is blocked by a TRPV4 antagonist and recapitulated by a TRPV4 
agonist under normothermic (37 oC) conditions. The absence of any additive effect between 
pre-treatment with TRPV4 agonist and its level at the time of hypothermic intervention, could 
be due to receptor internalization; which could explain the additive effect seen when cells are 
exposed to the intervention and the agonist at the same time. 
 
It is thought that AQP4 deletion/knockdown is protective and AQP4 overexpression is 
harmful in animal models of early brain oedema (Verkman et al., 2006). We suggest that 
some of the deleterious effects of hypothermic intervention in oedema that have been 
reported (Lazaridis & Robertson, 2016) may be mediated by increased AQP4 surface 
expression via a TRPV4/calmodulin-dependent relocalization mechanism. Further work 
showing inhibition of human astrocytic swelling in the presence of calmodulin and/or TRPV4 
inhibitors would further support the role of AQP4 in astrocytic swelling in stoke and traumatic 
injury.  
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Separating the mechanisms involved in the beneficial and damaging effects of hypothermic 
intervention may allow us to further refine the clinical value of hypothermia for oedema 
prevention following stroke or TBI. In the future, further, co treatment with putative AQP4 
inhibitors targeting the sub-cellular relocalization pathway would allow exploitation of the 
neuroprotective effects of hypothermia whilst mitigating any harmful effects. 
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Figure 2 
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Figure 3 
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Figure 4: 
 
 
 
 
